BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19936703)

  • 21. Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
    Chowdhury S; Wang S; Dunai J; Kilpatrick R; Oestricker LZ; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
    PLoS One; 2016; 11(6):e0156852. PubMed ID: 27304975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms through which a small protein and lipid preload improves glucose tolerance.
    Tricò D; Baldi S; Tulipani A; Frascerra S; Macedo MP; Mari A; Ferrannini E; Natali A
    Diabetologia; 2015 Nov; 58(11):2503-12. PubMed ID: 26224101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting and stimulated glucagon-like peptide-1 exhibit a compensatory adaptive response in diabetes and pre-diabetes states: A multi-ethnic comparative study.
    Chong SC; Sukor N; Robert SA; Ng KF; Kamaruddin NA
    Front Endocrinol (Lausanne); 2022; 13():961432. PubMed ID: 36157456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of transoral gastroplasty on glucose homeostasis in obese subjects.
    Leccesi L; Panunzi S; De Gaetano A; Familiari P; Iaconelli A; Guidone C; Mazzarella A; Costamagna G; Mingrone G
    J Clin Endocrinol Metab; 2013 May; 98(5):1901-10. PubMed ID: 23543657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
    Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
    Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?
    Wang X; Liu J; Li C; Zhao M; Liu L; Guan Q; Zhang H; Zhang X; Gao L; Zhao J; Song Y
    Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29135069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions - a narrative review.
    Huber H; Schieren A; Holst JJ; Simon MC
    Am J Clin Nutr; 2024 Mar; 119(3):599-627. PubMed ID: 38218319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.